Cellivate Technologies
PrivateLast Round
Seed
Aug 6, 2024
Total Funding Raised
$1.19M
Company Overview
Cellivate Technologies operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Seed round in August 2024.
Cellivate Technologies is a biotechnology company that develops and manufactures animal-free cell culture solutions and proprietary platform technologies for the pharmaceutical, cultivated meat, and cosmeceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Fashion & Beauty, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellivate Technologies Comparables
Compare Cellivate Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Smart MCs | 83% | |
| Gelatex Technologies | 81% | |
| Multus Biotechnology | 80% |
For institutional investors. Book with your work email.
Cellivate Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 6, 2024 | ||||
| Accelerator | Jun 7, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellivate Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NUS Graduate Research Innovation Programme | Accelerator |
| Hatcher+ | Seed |
| Venture Catalysts | Seed |
| Venture Catalysts | Seed |
| Antler | Seed |
| We Founder Circle | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 60% QoQ from 5 to 8 employees.
- Jan 23, 2025
Monthly visitors increased 192% MoM.
For institutional investors. Book with your work email.
Cellivate Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellivate Technologies's valuation, stock price, and market status.
Is Cellivate Technologies a public or private company?
Cellivate Technologies is a private company.
What is the current stock price of Cellivate Technologies?
Cellivate Technologies is a private company, so its shares have no public market price. Caplight tracks Cellivate Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellivate Technologies worth (valuation)?
Valuation information for Cellivate Technologies is not publicly available.
Can I buy Cellivate Technologies stock?
Cellivate Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellivate Technologies's last funding round?
Cellivate Technologies's most recent funding round was Seed on August 6, 2024.
Who are the main investors in Cellivate Technologies?
Key investors in Cellivate Technologies include Antler.
Will Cellivate Technologies IPO soon?
No public IPO plans have been announced for Cellivate Technologies.
How can I track Cellivate Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Cellivate Technologies's shares on secondary markets.